Founded in 2008, Recombinetics focused its early-stage development on the application of precision genetic technologies in animals and active patent filings. Development of advanced gene-editing technologies for commercial purposes began in 2011.
Today, Recombinetics is widely recognized as the leader in livestock gene-editing and associated applied technologies for biomedical research, regenerative medicine, and animal agriculture.
We have a rich history as innovators and early adopters of molecular tools and methods for animal gene editing. When paired with our experienced teams focused on bioinformatics, cell engineering, embryology, stem cell biology, and animal husbandry, we’re able to add value to livestock and make pivotal changes in human health and longevity.
Recombinetics’ first gene-edited animals are generating revenues today with a pipeline of animals under development for the large biomedical and food animal markets.